Starling Oncology (STLNW) Cash from Investing Activities Growth (3y) (2023 - 2026)
Powered by 
Analysis
Starling Oncology (STLNW) Cash from Investing Activities Growth (3y) (2023 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Davita | 11.90 Bn | 11.22 Bn | 1.16 Bn | 17.59% |
| 2 | RadNet | 5.52 Bn | 4.79 Bn | 88.08 Mn | -16.35% |
| 3 | Fresenius Medical Care AG | 4.79 Bn | 4.09 Bn | 1.52 Bn | -29.42% |
| 4 | Concentra Group Holdings Parent | 4.26 Bn | 4.10 Bn | 192.10 Mn | - |
| 5 | Privia Health | 2.57 Bn | 2.15 Bn | - | -441.99% |
| 6 | Pediatrix Medical | 2.15 Bn | 1.74 Bn | - | 37.13% |
| 7 | Progyny | 2.11 Bn | 1.87 Bn | 89.30 Mn | 27.25% |
| 8 | Surgery Partners | 1.84 Bn | 1.63 Bn | 622.10 Mn | 34.73% |
| 9 | U S Physical Therapy | 1.17 Bn | 1.15 Bn | 41.94 Mn | 2.82% |
| 10 | Starling Oncology | 4.13 Mn | -36.96 Mn | 27.17 Mn | -26.75% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -26.75% |
| Mar 31, 2026 | -27.17% |
| Dec 31, 2025 | 68.07% |
| Sep 30, 2025 | 80.98% |
| Jun 30, 2025 | 50.99% |
| Mar 31, 2025 | 41.36% |
| Dec 31, 2024 | 42.33% |
| Sep 30, 2024 | 134.83% |
| Jun 30, 2024 | 217.29% |
| Mar 31, 2024 | 148.84% |
| Dec 31, 2023 | -62.54% |